Globe NewsWire News Distribution Service

Details

Written by Globe NewsWire Press Releases

Category: Globe NewsWire News Distribution Service

Published: 09 April 2025

Created: 09 April 2025

Last Updated: 09 April 2025

Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced preliminary, unaudited revenue for the quarter ended March 31, 2025.

Posted: 2025-04-09 13:05:00

Get Full News Story On GlobeNewsWire Press Release Service

Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

• Prev
• Next

Related Bing News Search Results

Press Release: PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million - Newscast

PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates

Fri, 09 May 2025 09:00:00 GMT Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 15 cents in first-quarter 2025, narrower than the year-ago adjusted loss of 26 cents ...

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2025 Earnings Call Transcript

Fri, 09 May 2025 05:37:17 GMT Q1 2025 Earnings Call Transcript May 8, 2025 Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.15, expectations were $-0.19. Operator: Good afternoon, everyone.

Pacbio adjusts 2025 revenue guidance to $150M-$170M amid macroeconomic challenges

Thu, 08 May 2025 16:10:00 GMT Management revised full-year 2025 revenue guidance to $150 million-$170 million, reflecting adjustments due to recent macroeconomic developments. The company expects non-GAAP gross margins to be ...

PacBio Announces First Quarter 2025 Financial Results

Thu, 08 May 2025 13:35:00 GMT GAAP net loss for the first quarter of 2025 was $426.1 million, compared to $78.2 million for the first quarter of 2024. Non-GAAP net loss for the first quarter of 2025 was $44.4 million, compared to ...

PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

Wed, 09 Apr 2025 07:05:00 GMT Our preliminary revenue ... run-rate by $45 million to $50 million by year end in relation to its prior guidance of $270 million to $280 million. Following the reductions, PacBio aims to focus ...